Clinical Trial Update: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemotherapy with or without immunotherapy for peritoneal mesothelioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Mesothelioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Peritoneal Malignant Mesothelioma | Phase 2 | Status: RECRUITING